Introduction {#sec1}
============

A common human and animal opportunistic pathogen *Staphylococcus aureus* occurs mostly in the skin and/or nose vestibule mucous membrane as consistent of natural microflora in healthy individuals. Colonization can lead to an invasive mode of infection under particular conditions of a host organism, mostly immunodeficiency, surgical interventions or longitudinal hospitalization of patients ([@bib15]; [@bib21]). The European Centre for Disease Prevention and Control alarms that the most antimicrobial-resistant healthcare-associated infections are caused by the methicillin-resistant *S. aureus* (MRSA). Estimating the level of distribution, the MRSA isolates are responsible for 10% to 25% of all staphylococcal infections in Poland; in Slovakia, these rates are even higher (25% to 50%). Moreover, an increasing problem is the expansion of community-acquired MRSA ([@bib7]).

Staphylococcal strains carrying antimicrobial-resistance genes colonize a vast range of animal species, especially household or livestock animals, with clear evidence of the intra-species transmission of staphylococci ([@bib2]; [@bib1]).

Under particular conditions, *S. aureus* causes infections, and become high-risk pathogens due to several virulence determinants such as toxins and enzymes combined with other survival strategies of bacteria like antibiotic resistance and biofilm production ([@bib1]). An important staphylococcal strategy is to damage host cell membranes, caused by hemolysins, bi-component leukocidins, and phenol soluble modulins. For example, α-hemolysin and bi-component leukocidins act as pore-forming toxins, while β-haemolysin is sphingomyelinase, which hydrolyzes lipids of plasma membrane into ceramide and phosphorylcholine ([@bib1]). Additionally, α-hemolysin and Panton-Valentine leucocidin (PVL) promote apoptosis of phagocytes ([@bib31]). Another group of virulence factors is an enterotoxin superfamily. These toxins are responsible for staphylococcal food poisoning, but they also affect some immune system cells, with further consequences ([@bib36]).

*S. aureus* strains also secrete a variety of enzymes. Proteases include a vast group of secreted enzymes, such as aureolysin, serine proteases, and staphopains, which are engaged in the evasion of complement-mediated bacterial killing ([@bib16]; [@bib28]; [@bib22]). Nuclease, another extracellular enzyme, degrades neutrophil extracellular traps (NETs), providing the strain resistant to NET-mediated killing ([@bib35]; [@bib23]). *S. aureus* also produces lipase, which lyses triglycerides to free fatty acids -- but the biological function of this process is still unknown ([@bib5]). Finally, extracellular urease is involved in biofilm regulation and protection against low pH. Urease catalyzes the hydrolysis of urea and neutralizes acids using ammonia ([@bib34]). Triggering calculus formation, an increased pH level plays a significant role in urinary tract diseases ([@bib23]).

The progress of *S. aureus* infections depends on the secretion of surface proteins, numerous extracellular toxins, and enzymes that destruct host cells and tissues ([@bib1]). Due to this fact, this work aimed to recognize the characteristic properties of *S. aureus* strains based on phenotypic and genetic features such as the production of enzymes and toxins, their resistance profiles and MRSA detection. Firstly, the strains were genetically characterized by microarrays' profiling and *spa* typing. Secondly, the human and animal strains were compared based on microarray testing and phenotypic manifestations, together with the analysis of their relatedness or differences between them.

Experimental {#sec2}
============

Materials and Methods {#sec3}
---------------------

**Strains collection.** Fifty-three not duplicate *S. aureus* strains were isolated from deep tissue infections of ambulatory patients and from animals (Table [I](#tbl1){ref-type="table"}). The number of strains was sufficient to group the strains based on their similarities, to define dominant properties of the strains and groups, and to compare them. The 26 human strains were obtained from four medical institutions and universities: (i) 11 isolates from the Centre of Microbiological Research and Autovaccines and different hospital wards in Kraków (Poland), (ii) 11 Poultry-like protein A positive (P-like pA+) isolates from the Medical University of Gdańsk, (Poland), and (iii) four isolates from the Spirito Santo Hospital, Pescara (Italy). Among these strains, 21 isolates originated from the following infections: wound infections (n = 9), boils (n = 3), deep skin lesions (n = 2), ulcers (n = 2), conjunctivitis (n = 2), blood (n = 1), cyst (n = 1), and pus (n = 1); the other five were isolated from throats (n = 3) and nose swabs (n = 2). Moreover, the collection was enriched with 11 P-like pA+ strains isolated from patients in Gdańsk, an atypical origin of P-like pA+ biotype, although there is no information about the link between these strains occurrence and patient's employment. Interestingly, these strains are usually detected in meat products, in people having direct contact with meat, and in the places where fresh meat occurs in abundance ([@bib25]).

###### 

A list of the strains collected, their origin and place of isolation.

![](pjm-68-1-093-t001)

  Strain no.   Host     Lesions/Material   Place of origin
  ------------ -------- ------------------ ----------------------------
  1            human    wound infection    Kraków (Poland)
  2            human    cyst               Kraków (Poland)
  3            human    wound infection    Kraków (Poland)
  4            human    wound infection    Kraków (Poland)
  5            human    wound infection    Kraków (Poland)
  6            human    wound infection    Gdansk (Poland)
  7            human    wound infection    Gdansk (Poland)
  8            human    boil               Gdansk (Poland)
  9            human    boil               Gdansk (Poland)
  10           human    boil               Gdansk (Poland)
  11           human    throat             Gdansk (Poland)
  12           human    pus                Gdansk (Poland)
  13           human    throat             Gdansk (Poland)
  14           human    throat             Pescara (Italy)
  15           human    skin infection     Pescara (Italy)
  16           human    blood              Pescara (Italy)
  17           human    skin infection     Pescara (Italy)
  18           human    nose swab          Gdansk (Poland)
  19           human    ulcer              Gdansk (Poland)
  20           human    ulcer              Gdansk (Poland)
  21           human    wound infection    Kraków (Poland)
  22           human    wound infection    Kraków (Poland)
  23           human    conjunctivitis     Kraków (Poland)
  24           human    conjunctivitis     Kraków (Poland)
  25           human    wound infection    Kraków (Poland)
  26           human    nose swab          Kraków (Poland)
  27           animal   eczema             Gdansk (Poland)
  28           animal   eye                Gdansk (Poland)
  29           animal   eye                Gdansk (Poland)
  30           animal   throat             Gdansk (Poland)
  31           animal   skin infection     Wroclaw (Poland)
  32           animal   mastitis           Košice (Slovakia)
  33           animal   mastitis           Košice (Slovakia)
  34           animal   mastitis           Košice (Slovakia)
  35           animal   mastitis           Košice (Slovakia)
  36           animal   mastitis           Košice (Slovakia)
  37           animal   mastitis           Košice (Slovakia)
  38           animal   mastitis           Košice (Slovakia)
  39           animal   mastitis           Leczna (Poland)
  40           animal   mastitis           Leczna (Poland)
  41           animal   mastitis           Lubartów (Poland)
  42           animal   mastitis           Leczna (Poland)
  43           animal   mastitis           Leczna (Poland)
  44           animal   mastitis           Luków (Poland)
  45           animal   mastitis           Luków (Poland)
  46           animal   mastitis           Gawrolin (Poland)
  47           animal   mastitis           Swidnik (Poland)
  48           animal   mastitis           Swidnik (Poland)
  49           animal   mastitis           Swidnik (Poland)
  50           animal   mastitis           Tomaszów Lubelski (Poland)
  51           animal   mastitis           Tomaszów Lubelski (Poland)
  52           animal   mastitis           Tomaszów Lubelski (Poland)
  53           animal   mastitis           Tomaszów Lubelski (Poland)

The 27 animal strains were isolated from animals, which had daily physical contact with people. The strains were obtained from four veterinary institutions and universities: (i) 15 bovine isolates from the Faculty of Biology and Animal Breeding, University of Life Sciences, Lublin (Poland); (ii) seven bovine isolates from the Institute of Animal Physiology, Centre of Biosciences, Slovak Academy of Sciences, Kosice (Slovakia); (iii) four canine isolates from the Medical University of Gdańsk (Poland); and (iv) one canine isolate from the Faculty of Veterinary Medicine, University of Environmental and Life Sciences, Wroclaw (Poland). Only one animal strain was isolated from throat infection of a dog while the others were isolated from eczema, eye, or skin infections. All the strains were isolated from animals inhabiting human environments with frequent contact with people what facilitates the inter-genus transmission of bacteria.

Taking into consideration a widespread and active transmission of staphylococci, the bacteria from various sources and different geographic regions were used in this research.

**Antibiotic susceptibility testing.** Before molecular analysis the antibiotic susceptibility testing was performed using the disc diffusion according to the European Committee on Antimicrobial Susceptibility Testing ([@bib8]). The bacteria were cultivated for 24 hours at 37°C on MH agar plates with antibiotic discs. The 24 h incubation is required for cefoxitin susceptibility testing according to according to EUCAST ([@bib37]). The strains were tested using a set of 12 antibacterial agents, including the following: i) aminoglycosides: amikacin and gentamicin; ii) beta-lactams: amoxicillin with clavulanic acid, cefoxitin, and penicillin; iii) fluoroquinolones: ciprofloxacin and norfloxacin; iv) lincosamides: trimethoprim/sulfamethoxazole; v) macrolides: clindamycin and erythromycin; and others: chloramphenicol and doxycycline. The diameter of the transparent zones of growth inhibition was measured, and clinical breakpoints were evaluated.

**Evaluation of enzymatic activity.** A single colony of each bacterial strain was transferred from a TSA agar plate (Sigma Aldrich, Merck KGaA, Darmstadt, Germany) to specific media, including substrates dedicated to particular enzymes: a TSA agar plate supplemented with 10% of skim milk proteins; a blood agar plate with 5% sheep blood (Graso Biotech, Starogard Gdański, Poland); a TSA agar plate enriched with 2% Tween 80; 10% of 1M CaCl~2~; DNase test agar (Becton Dickinson, New Jersey, USA); and Christensen's Urea Agar Base (REFE112L), containing 40% of Urea Solution (EBO48), (Becton Dickinson, New Jersey, USA) for proteolysis testing, hemolysis testing, lipases activity testing, nucleases activity testing, and ureases activity testing, respectively. Bacterial strains on appropriate plates were then cultured for 24 hours at 37°C. To evaluate proteolysis activity, the diameters of transparent zones around the colonies were measured ([@bib27]). To rate types of hemolysis the transparent zones for β-hemolysis (including the second zone observed in double β-hemolysis) and dark-green opalization for α-hemolysis were evaluated ([@bib27]). Lipase activity was measured by the size of a turbidity zone around colonies, nuclease activity -- by the size of a transparent zone after HCl addition to the culture test, while urease activity -- by the color change of the medium from yellow to purple ([@bib4]; [@bib6]; [@bib26]). To evaluate enzymatic activity, a sample was assessed as either negative (no activity) or positive (with low, moderate, high or very high activity).

**Molecular techniques. The *spa* typing.** The *spa* typing technique was used following [@bib1]. The method is based on the sequence analysis of amplified fragments of the X region of the protein A gene, resulting in *spa* types, assigned by the Ridom StaphType software version 2.1.1 (Ridom GmbH, Würzburg, Germany) and the Ridom SpaServer (<http://www.spaserver.ridom.de>). Based on *spa* types, *spa* clonal complexes (*spa*-CCs) are then calculated using the Based Upon Repeat Pattern (BURP) algorithm with the following parameters: (i) no exclusion criteria related to the number of repeats were used; (ii) cost equal to 4; (iii) a cluster composed of 2 or more related *spa* types was regarded as a clonal complex (CC); and (iv) a *spa* type that was not grouped into a CC was considered a singleton.

**Microarray analysis.** Microarray assays were done using the StaphyType system (StaphyType, Alere Technologies, Jena, Germany). The StaphyType kit allows the simultaneous detection of 334 *S. aureus* target sequences, including approximately 170 distinct genes and their allelic variants. The DNA microarray procedures were carried out according to the manufacturer's instructions. According to [@bib17] methodology, the strains were automatically assigned to CCs or sequence types (STs) by the StaphyType software. The results for individual genes were converted into the following scale: A = positive, T = negative, and C = ambiguous.

Results {#sec4}
=======

**Antibiotic susceptibility testing.** All the *S. aureus* strains tested were susceptible to trimethoprim/sulfamethoxazole (Table [II](#tbl2){ref-type="table"}). Five human (19%) and ten animal (37%) strains were susceptible to all the antibiotics tested. Eight strains (15%), the Slovakian bovine strains together with one human strain originated from Kraków were multi-resistant (resistant to more than three antibiotics). The highest resistance rate was observed for penicillin (n = 33; 62%), with 17 human (65%) and 16 animal (59%) resistant strains. The detection of resistance to cefoxitin helped to identify nine strains (two from humans and seven from animals) as methicillin-resistant (MRSA), and one of them did not exhibit resistance to benzylpenicillin/amoxicillin. Among the MRSA strains, bovine strains from Slovakia (n = 7) were resistant to other antibiotics. All of these strains demonstrated resistance to erythromycin and clindamycin, and they were classified to have an inducible MLS~B~ (macrolides-lincosamides-streptogramin B resistance) phenotype. Bovine strains of non-Slovakian origins were susceptible to the majority of antibiotics tested. Among methicillin-susceptible *S. aureus* (MSSA) strains, 18 (54%) demonstrated resistance only to penicillin/amoxicillin, two (6%) to penicillin and doxycycline, four (12%) to penicillin and erythromycin, and one to chloramphenicol and aminoglycosides. The susceptibility rate was high for both human and animal isolates. In both collections, however, the proportions of strains resistant to antimicrobials other than β-lactams were equal.

###### 

Antibiotic susceptibility of *S. aureus* strains. MRSA strains are bolded in text.
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  Antibiotic                              Number of strains                
  --------------------------------------- ------------------- ------------ ------------
  Resistant to all antibiotics tested     0 (0)               0 (0)        0 (0)
  Multi-resistant                         1 (4)               7 (26)       8 (15)
  BEN                                     17 (65)             16 (59)      33 (62)
  AMC                                     2 (8)               7 (26)       9 (17)
  **FOX**                                 **2 (8)**           **7 (26)**   **9 (17)**
  SXT                                     0 (0)               0 (0)        0 (0)
  CHL                                     1 (4)               1 (4)        2 (4)
  DOX                                     3 (12)              1 (4)        4 (8)
  ERY                                     6 (23)              8 (30)       14 (26)
  CLI                                     0 (0)               7 (26)       7 (13)
  AMI                                     2 (8)               2 (7)        4 (8)
  GEN                                     2 (8)               0 (0)        2 (4)
  CIP                                     0 (0)               4 (15)       4 (8)
  NOR                                     0 (0)               4 (15)       4 (8)
  Susceptible to all antibiotics tested   5 (19)              10 (37)      15 (28)

BEN: benzylpenicillin, AMC: amoxicillin with clavulanic acid, FOX: cefoxitin, SXT: trimethoprim/sulfamethoxazole, CHL: chloramphenicol, DOX: doxycycline, ERY: erythromycin, CLI: clindamycin, AMI: amikacin, GEN: gentamicin, CIP: ciprofloxacin, NOR: norfloxacin. Multi-resistant -- resistant to more than three antibiotics.

**Enzymatic activity.** In the *S. aureus* collection, 42 strains (79%) demonstrated β-hemolytic activity: 18 strains showed a double zone of hemolysis ([@bib29]), and 24 strains presented a single zone of hemolysis; 11 strains (21%) did not demonstrate hemolysis (Fig. 1.1). Double-zone hemolysis occurred mostly in human strains (n = 12, 23%), and 17 animal strains showed regular β-hemolysis zone. Both human and animal populations showed similar number of β-hemolytic strains.

Fifty-two (98%) strains demonstrated proteolytic activity. Most of the strains showed low (n = 21, 40%) or moderate (n = 23, 43%) proteolysis. Seven (13%) strains, of which five were the human origin, showed high proteolytic activity. Most human (n = 12) and animal (n = 11) strains showed moderate while 14 animal strains (n = 14) showed low proteolytic activity (Fig. 1.2).

All the strains showed nuclease activity, usually high (n = 28, 53%) or moderate (n = 20, 38%). The animal strains (n = 22; 81%) showed higher nuclease activity than human strains, which mostly exhibited moderate activity (n = 16; 62%).

Twenty-nine (55%) strains showed lipase activity, high activity was presented by nine strains (16%; five were human and four animal), moderate activity exhibited 13 strains (25%; seven were human and six animal), and low activity -- seven strains (13%; three were human and four animal). Twenty-four (45%) strains did not exhibit any lipase activity. The human and animal bacteria collections showed an almost identical rate of lipase activity.

Forty-four (83%) strains demonstrated urease activity, but in most cases (n = 19, 36%) it was low. Six animal and four human strains showed very high urease activity (n = 10, 19%), three human and seven animal strains showed high activity (n = 10, 19%), and eight human strains showed moderate activity (15%). Nine strains (five from animals and four from humans; n = 9; 17%) did not exhibit urease activity. Human and animal strains did not differ in terms of urease activity. Figure [1](#fig1){ref-type="fig"} shows the results of phenotypic testing.

![Positive results of phenotypic tests.\
Columns A: human strains, B: animal strains. 1.1. Total number of positive results for hemolysins activity. Black: double-zone β-hemolysis; white: single-zone β-hemolysis. 1.2. Total number of positive results for proteases, nuclease, lipase and urease activity. Black, low activity. Dark grey, moderate activity. Grey, high activity. White, very high activity.](pjm-68-1-093-g001){#fig1}

**The *spa* typing.** Based on the *spa* typing, 35 *S. aureus* strains were assigned into 20 *spa* types (Table [III](#tbl3){ref-type="table"}). Eighteen singletons were found, including the following *spa* types: t053, t091, t127, t150, t335, t723, t793, t3165, t4087, t5447, t14393, t14394, t14403, and t14404. Table [III](#tbl3){ref-type="table"} shows bacterial isolates assigned to *spa* types and clonal complexes together with their resistance and virulence genes. Figure [2](#fig2){ref-type="fig"} presents the results of BURP analysis, which demonstrates the clonal complexes based on the *spa* gene sequence similarities. Interestingly, *spa*-CC 045 was previously described as *spa*-CC 002 using Ridom StaphType software version 1.4 (Ridom GmbH, Würzburg, Germany), but a further update to version 2.1.1 resulted in changing the founder strain within the clonal complex.

###### 

The results of the *spa* typing. Bacterial isolates were assigned to *spa* types and clonal complexes (CCs).
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  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Strain number              *spa* types   Sequence type (ST)[\*](#FNt1){ref-type="fn"}   Clonal complex                                                   Resistance and virulence genes
  -------------------------- ------------- ---------------------------------------------- ---------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  26                         t008          ST-8, ST-427, ST-250, ST-254                   *spa*-CC 008.051                                                 Human strains: 26/23\
                                                                                                                                                           Resistance: ***blaZ/I/R*** (+/-), *tetEfflux, fosB*\
                                                                                                                                                           Enterotoxins: ***sea*** **(-/+)**, ***sed*** **(+/-),** ***seg*** **(+/-)**, ***sej*** **(+/-)**, ***ser*** **(+/-)**\
                                                                                                                                                           Enzymes within hemolysins: *sak, hla, hlb, **lukM/luk F*** **(+/-)***, hlgA, lukD, lukE, lukX*,\
                                                                                                                                                           Proteases: *aur, splA, splB, splE*\
                                                                                                                                                           Adhesion and biofilm formation: *bbp, fnbB, map, sdrC, sdrD, sas*G

  23                         t051          ST-250, ST-254                                                                                                  

  4                          t015          ST-45                                          *spa*-CC 015.031                                                 Human strains: 4/21\
                                                                                                                                                           Resistance: ***mecA*** **(+/-)***, blaZ/I/R, **erm(A)*** **(-/+)***, tetEfflux*\
                                                                                                                                                           Enterotoxins: ***seb*** **(-/+),** *sec, seg, **sej*** **(+/-)***, **sel*** **(-/+)***, sei, sem, sen, seo, seu, egc-cluster*\
                                                                                                                                                           Enzymes within hemolysins: *sak, hla, hlgA, lukX*,\
                                                                                                                                                           Proteases: *aur*\
                                                                                                                                                           Adhesion and biofilm formation: *bbp, cna, fnbB, **map*** **(+/-)**, sdrC, sdrD

  21                         t031          ST-45                                                                                                           

  25                         t017          nd                                             *spa*-CC 017                                                     Human strains: 25/5/animal strain: 31\
                                                                                                                                                           Resistance: ***blaZ/I/R*** **(-/+/+)**, ***erm(A)*** **(-/+/-)***, **tet(K)*** **(-/-/+)***, tetEfflux, fosB*\
                                                                                                                                                           Enterotoxins: *seg, sei, sem, sen, seo, seu, egc-cluster*\
                                                                                                                                                           Enzymes within hemolysins: ***sak*** **(+/+/-)**, *hla, hlb, hlgA, **lukX*** **(+/-/-)**, ***lukX*** **(-/-/+)**\
                                                                                                                                                           Proteases: *aur, splE*\
                                                                                                                                                           Adhesion and biofilm formation: *bbp, cna, **fnbB*** **(+/+/-)***, **map*** **(-/+/+)***, sdrC, sdrD*

  5                          t021          ST-30, ST33, ST-55                                                                                              

  16, 31                     t018          ST-30, ST36, ST-38                                                                                              

  15                         t026          ST-45, ST-47                                   *spa*-CC 026.2642                                                Human strains: 15/2\
                                                                                                                                                           Resistance: ***mecA*** **(-/+)**, ***erm(C)*** **(-/+)**, ***addD*** **(-/+)**, ***mupR*** **(-/+)***, tetEfflux, **fosB*** **(+/-)**, ***cat*** **(-/+)**\
                                                                                                                                                           Enterotoxins: *sec, seg, sei, **sel*** **(+/-)***, sem, sen, seo, seu, egc-cluster*\
                                                                                                                                                           Enzymes within hemolysins: *sak*, *hla, hlgA, **lukX*** **(-/+)**\
                                                                                                                                                           Proteases: *aur*\
                                                                                                                                                           Adhesion and biofilm formation: ***bbp*** **(-/+)***, **cna*** **(+/-)***, fnbB, map, sdrC, **sdrD*** **(-/+)**

  2                          t2642         nd                                                                                                              

  50, 51, 52, 53             t14395        nd                                             *spa*-CC 14395.14396                                             Animal strains: 50/51/52/53\
                                                                                                                                                           Resistance: *tetEfflux, fosB*\
                                                                                                                                                           Enterotoxins: *seg, sei, sem, sen, seo, seu, egc-cluster*\
                                                                                                                                                           Enzymes within hemolysins: *hla, hlb, hlgA, lukX*\
                                                                                                                                                           Proteases: *aur*\
                                                                                                                                                           Adhesion and biofilm formation: *bbp, fnbB, map, sdrC, **sdrD*** **(51, 53: +, 50, 52: -)**

  32, 34                     t002          ST-5, ST-231                                   *spa*-CC 045                                                     Animal strains: 32/34/33/35\
                                                                                                                                                           Resistance: ***mecA,*** ***blaZ/I/R*** **(strain no. 34: -)***, **erm(A)*** **(strains no. 34, 35: +),** *addD, tetEfflux, **cat*** **(strain no. 35: +)***, fosB*\
                                                                                                                                                           Enterotoxins: ***sea*** **(strains no. 33, 35: +)**, ***sed*** **(strain no. 34: -)***, seg, sei, **sej*** **(strain no. 34: -)***, sem, sen, seo, **ser*** **(strain no. 34: -)***, seu, egc-cluster*\
                                                                                                                                                           Enzymes within hemolysins: *sak, hla, hlb, hlgA, lukD, lukE, lukX*\
                                                                                                                                                           Proteases: *aur, splA, splB*\
                                                                                                                                                           Adhesion and biofilm formation: *bbp, **fnbB*** **(strains no. 33, 35: +),** *map, sdrC, sdrD, sasG*

  33                         t003          ST-5, ST-225                                                                                                    

  33                         t003          ST-5, ST-225                                                                                                    

  47, 48, 49                 t010          ST-5                                           Animal strains: 47/48/49\                                        
                                                                                          Resistance: *blaZ*/*I*/*R, tetEfflux, fosB*\                     
                                                                                          Enterotoxins: *seg, sei, sem, sen, seo, seu, egc-cluster*\       
                                                                                          Enzymes within hemolysins: *hla, hlb, hlgA, lukD, lukE, lukX*\   
                                                                                          Proteases: *aur, splA, splB*\                                    
                                                                                          Adhesion and biofilm formation: *bbp, map, sdrC, sdrD, sasG*     

  1, 7, 10, 11, 12, 18, 19   t084          ST-15, ST-18                                   *spa*-CC084                                                      Human strains: 1/7/10/11/12/18/19/8/20\
                                                                                                                                                           Animal strain: 28\
                                                                                                                                                           Resistance: ***blaZ/I/R*** **(strains no. 12, 18: -)***, **tet(K)*** **(strains no. 7, 12, 19, 20: +)***, tetEfflux, **fosB*** **(strain no. 7: -)**\
                                                                                                                                                           Enterotoxins: -\
                                                                                                                                                           Enzymes within hemolysins: ***sak*** **(strain no. 28: +)***, **hla*** **(strains no. 10, 28: -)***, **lukM/lukF*** **(strains no. 19, 20: +)**, ***hlgA*** **(strains no. 10, 28: -)***, **lukD*** **(strain no. 10: -)**, ***lukE*** **(strains no. 18, 19: +)**, ***lukF*** **(strain no. 20: +)**, ***lukX*** **(strains no. 18, 19, 20: +)**\
                                                                                                                                                           Proteases: ***aur*** **(strains no. 10, 11, 28: -)***, splA, splB, **splE*** **(strains no. 10, 28: -)**\
                                                                                                                                                           Adhesion and biofilm formation: *bbp* **(strains no. 10, 8: -)**, *fnbB* **(strain no. 11: -)***, map, sdrC, sdrD*, *sasG*

  8,9                        t9490         nd                                                                                                              

  28                         t144          nd                                                                                                              

  20                         t491          nd                                                                                                              

  38                         t2393         nd                                             *spa*-CC 2393.5163                                               Animal strains: 38/36/37\
                                                                                                                                                           Resistance: ***mecA**, blaZ*/*I*/*R, erm(C), tet(K), tetEfflux*\
                                                                                                                                                           Enterotoxins: *sea*\
                                                                                                                                                           Enzymes within Hemolysins: *sak, hla, hlb, hlgA, lukD, lukE, lukX*\
                                                                                                                                                           Proteases: *aur, splA, splB*\
                                                                                                                                                           Adhesion and biofilm formation: *bbp, fnbB, map, sdrC, sdrD, sasG*
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

The proposed sequence type retrieved from Ridom SpaServer. Genes exhibited by all the analyzed strains: hemolysins: *hld*, *luk F, lukS, lukY*; proteases: *sspA, sspB, sspP*; adhesion and biofilm formation: *icaA*, *icaC, icaD, clfA, clfB, ebh, eno, fib, ebpS, fnbA, vwb.*

![The results of BURP analysis. The 20 *spa* types were assigned to proper clonal complexes. Eighteen singletons were found among the 53 strains analyzed. Black circles represent the *spa* types assigned to the proper clonal complexes, and the blue circles represent the ancestor within the clonal complex.](pjm-68-1-093-g002){#fig2}

The human strains belonged into more different *spa*-CCs than animal strains did. Most human strains (n = 10) and only one animal strain were assigned to *spa*-CC 084. Interestingly, these ten human strains and one canine strain originated from the same city Gdańsk. Other *spa*-CCs of human strains were as follows: *spa*-CC 008.051 (n = 2), *spa*-CC 017 (n = 3), *spa*-CC 015.031 (n = 2), and *spa*-CC 026.2642 (n = 2). Among the animal strains, *spa*-CCs were also distinct, but there was a strong correlation between *spa*-CC and a place of strain isolation. The most numerous clonal complex was *spa*-CC 084 (n = 11). The geographic *spa* type division was distinctly observed among the strains originating from bovine mastitis infections. Four bovine strains originating from Tomaszów Lubelski were assigned to one *spa*-CC 14395.14396, four strains originating from Lęczna to *spa*-type t150, and two strains originating from Luków to *spa*-type t053. Among the bovine strains received from Kosice (Slovakia), two *spa*-CCs were reported: *spa*-CC 045 (n = 4) and *spa*-CC 2393.5163 (n = 3). The former *spa*-CC was also identified in Świdnik (n = 3).

**Microarray testing.** All the strains demonstrated positive results for the species markers: *gapA* (glyceraldehyde 3-phosphate dehydrogenase), *katA* (catalase), *coa* (coagulase), *spa* (*Staphylococcus* protein A), *sbi* (IgG-binding protein), *nuc* (thermostable nuclease), *fnbA* (fibronectin-binding protein A), *vraS* (sensor protein), *sarA* (staphylococcal accessory regulator A), *eno* (enolase), and *saeS* (histidine protein kinase). The presence of *nuc* gene was also confirmed phenotypically (Fig. [1](#fig1){ref-type="fig"}). Five strains presented negative results, and two strains -- ambiguous results for the 23S-rRNA gene, and they were probably caused by RNA contamination. The results for these strains were reliable because the number of ambiguous results did not exceed 3%. All isolates but one (n = 52; 98%) carried the *tetEfflux* gene, which encodes tetracycline efflux protein, and the *fosB* gene (n = 43; 81%), which confers resistance to fosfomycin and bleomycin. In 32 strains (17 from humans and 15 from animals), the genes involved in penicillin resistance by the production of β-lactamase (*blaZ, blaI*, and *blaR*) were detected; among these strains, eight were MRSA strains. Strains carrying the other resistance genes did not exceed 17%. The most prevalent resistance patterns were: *tetEfflux, fosB, and blaZ*/*I*/*R, tetEfflux, fosB* (Table [III](#tbl3){ref-type="table"}). The first one was carried by strains belonged to *spa-*CC 084 (n = 6; t084, t144, t9490), *spa-* CC 045 (n = 3; t010), and *spa-*CC 008.015 (n = 1, t008). Strains with *spa* type t010 were the only MSSA strains from the *spa-*CC 045. The other strain from *spa-*CC 008.015 (no. 23; t051), and two strains from *spa-*CC 084 (no. 9, 18), harbored the second most frequent pattern. The same resistance genes were present also in *spa-* CC 017 (n = 1; t021), and all of the strains from *spa-*CC 14395.14396. The animal strains of *spa-*CC 2393.5163 carried a unique resistance pattern among other strains from the collections (Table [III](#tbl3){ref-type="table"}).

These MRSA strains carried *mecA* or *mecR*, and associated with the SCC*mec* element genes for glicerophosphoryl-diester-phosphodiesterase (*upgQ*), and cassette chromosome recombinases (*ccrA-2, ccrB-2*). Four of these strains carried also potassium-transporting ATPases (*kdp* operon); a DNA-binding response regulator; the *mecI* gene; and *xylR*, encoding a pseudogene of xylose repressor. The most MRSA strains belonged to *spa-*CC 045 (n = 4), and *spa-*CC 2393.5163 (n = 3). Two strains carried the *mecA* gene and they were *blaZ*/*I*/*R* negative. One of them exhibited *spa* type t002 (*spa-* CC 045), and the other belonged to *spa* type t2642 (*spa-*CC 026.2642) (Table [III](#tbl3){ref-type="table"}).

All the 53 isolates harbored the δ-hemolysin gene, components of other hemolysins, and the leucocidin D component (*lukF*/*S, lukY, hl, hld, hldIII*). All but three strains carried also the gene for α-hemolysin (*hlgA*, n = 50; 94%); the β-hemolysin gene (*hlb*, n = 35, 66%); and the staphylokinase gene (*sak*, n = 24; 45%). The absence of both -- *hlb* and *sak* genes was a characteristic feature of P-like pA+ genotype of the strains in comparison to other human strains which carried *hlb* (n = 11) and *sak* (n = 12) gene in more than 70%. Lack of the *sak* genes were observed also in animal stains from t010, and t14395. On the other hand, the *hlb* gene was absent in human *spa-*CCs 026.2642 and 015.031. Human P-like pA+ strains were in majority grouped in *spa-*CC 084 (t084, t9490, t491), and two of them were classified as singletons (t335, t793). The characteristic property of these stains was also lack of enterotoxins genes.

Fifteen enterotoxin genes frequently occurred in human and animal strains from most regions, including *sea* (n = 11; 21%), *seb* (n = 2; 4%), *sec* (n = 3; 6%) *sed* (n = 5; 9%), *seg* (n = 25; 47%), *seh* (n = 1; 2%), *sei* (n = 24; 45%), *sej* (n = 5; 9%), *sel* (n = 3; 6%), *selm* (n = 24; 45%), *seln* (n = 24; 45%)*, selo* (n = 24; 45%), *ser* (n = 5; 9%), *selu* (n = 24; 45%), and *ego*-cluster (n = 24, 45%), which encodes enterotoxins *seg, sei, selm, seln, selo*, and *selu*. Although, strains from *spa* types t008, t2393, and t5163 carried only enterotoxin A gene (*sea*).

All the 53 isolates harbored the V8-protease gene (*sspA*) and staphopain A and B (*sspP, sspB*), and 47 strains (89%) carried the aureolysin gene (*aur*). Genes for serine proteases also were detected frequently: 20 human and 21 animal strains (n = 41; 77%) carried the *splA* and *splB* genes. Additionally, 10 animal and 20 human strains (n = 30; 57%) carried the *splE* gene, encoding serine protease E.

Adhesin and biofilm formation genes frequently occurred in the strains analyzed. All of them exhibited following genes: *icaA*/*C* (intercellular adhesion protein A/C)*, icaD* (biofilm PIA synthesis protein D), *clfA*/*B* (clumping factor A/B)*, ebh*/*ebpS* (cell wall-associated fibronectin-binding proteins)*, eno* (enolase)*, fib*/*fnbA* (fibrinogen binding proteins), and *vwb* (Willebrand factor). Strains from *spa-*CC 015.031, and *spa-*CC 017 carried *cna* (collagen-binding adhesin) genes, which differentiated them from other strains from the collections.

All the 53 isolates harbored the clumping factor genes (*clfA, clfB*), cell wall-associated fibronectin-binding protein gene ( *ebh, ebpS*), enolase gene (*eno*), fibrinogen-binding protein (*fib*), fibronectin-binding protein (*fnb*), immunodominant antigen B (*isaB*), heme/transferrin-binding protein (*isdA*), putative transporter protein (*ImrP*), and hyaluronate lyase A1 (*hysA1*). The capsule-5 encoding gene (*capsule 5*) occurred mostly in animal strains while the capsule-8 encoding gene's (*capsule 8*) rate was higher in human strains.

Discussion {#sec5}
==========

The research presented here aimed to characterize the properties of isolates of two particular collections of human and livestock *S. aureus* strains, using phenotypic and genetic methods, and to assess the compatibility of results between microarray and phenotypic manifestations. The investigation focused on the comparison of human and animal strains because studies have shown that animals are a reservoir of pathogens for people ([@bib24]). Therefore, dogs have been reported as hosts for MRSA strains, genetically closely related to human strains ([@bib32]; [@bib19]).

The next group of animal strains originated from cows. Transmission of bovine strains from cows and cow milk to people and the other way round has been reported as a result of close contact in the dairy environment ([@bib30]). Other authors reported a high share of nasal MRSA colonization among volunteers working in farms. However, only 6% MRSA contaminations survive more than 48 hours ([@bib2]). It has been shown that high persistence of multi-resistant isolates increases the importance of monitoring of intra-species strains transmission ([@bib24]).

Another way of bovine strains transmission is the contamination of dairy products ([@bib1]; [@bib20]), and as a result, foodborne infections in human. There was also shown that laboratory investigation detected *S. aureus* in stool samples of 15 patients who had gastrointestinal symptoms, and the strains isolated harbored the *seg, sei, selm, seln, selo*, and *selu* genes ([@bib33]). These results provided the convincing evidence of potential foodborne outbreaks caused by *S. aureus* strains, underlining the significance of bovine strain monitoring to human health prevention.

It was epidemiologically crucial to estimate the resistance to antibiotics for both human and animal pathogens, although the collected strains exhibited low rates of resistance. The low number of MRSA likely resulted from the origin of strains, because all the human strains were received from outdoor patients, and from canine or bovine strains usually presented methicillin-susceptible profiles ([@bib12]; [@bib1]). The human and animal collections did not differ in resistance profiles, despite methicillin resistance, which was higher in animal strains.

Detection of the appropriate genes with microarrays also tested all the strains' antibiotic resistance. MRSA strains (n = 9, 17%) were correctly identified by phenotypic antibiotic tests because all of these strains showed the presence of the *mecA* gene. Other genetic traits of antibiotic resistance differed from these phenotypically observed. For the *blaZ*/*I*/*R* genes, such differences occurred for three strains (two from humans and one from an animal). Two of them did not carry *blaZ*/*I*/*R* genes, but phenotyping showed their resistance to penicillin, and one of them presented an opposite correlation (there was no phenotypic resistance and the appropriate genes were present). The second situation probably resulted from the phenotypic method drawback, so the presence of *blaZ*/*I*/*R* genes confirmed by microarrays was recognized as a correct result. For some strains the antibiotic resistance genes presence did not correlate with the phenotypic manifestation: for chloramphenicol (n = 2), doxycycline (n = 6), erythromycin (n = 7), amikacin (n = 3), and gentamicin (n = 7). These data partially agree with results by others in which the occurrence rate of resistance genes was higher than the corresponding phenotypic manifestation of resistance ([@bib14]). In the present research, the resistance to antibiotics detected by phenotypic methods only, without any confirmation of the presence of resistance genes, was possibly a result of mutations or a novel or not tested resistance gene presence.

The next approach was to compare the phenotypic profiles to genetic ones, and for 23 isolates they differed. The *hla* gene was detected in 51 (96%) and *hlb* gene in 35 (66%) strains. These results suggest that hemolysin genes are widespread in staphylococcal populations, even if they do not show any phenotypic manifestation. Thus, there is a strong need to introduce molecular analyses into the hospital and veterinary laboratories, without which many strains may go unnoticed during standard laboratory examinations of patients and ill animals ([@bib18]). However, nuclease and protease phenotypic testing gave similar results to molecular analysis.

Furthermore, the human and animal strains were compared based on the microarray patterns, and as it was shown in other investigation, this was the most discriminatory method for strain characterization ([@bib11]). No specific feature clearly differentiated them when based on the microarray results that concerned resistance genes, virulence genes, adhesion and biofilm formation genes, and immune evasion assay. However, bovine mastitis strains from Poland harbored less resistance and virulence genes than human strains did; this result was in agreement with the recent studies by [@bib30]. Interestingly, the bovine strains from Slovakia showed multi-resistant profile. Microarray patterns also demonstrated the close similarity between strains originated from the same geographical places of isolation. However, the human P-like pA+ strains originated from Gdańsk showed slightly different microarray patterns than other strains. The reports have shown that the characteristic property of the P-like pA+ strains was lack of *hlb* and *sak* genes, and the present study confirmed this thesis ([@bib25]). Therefore, these strains did not contain any enterotoxin genes in opposite to other human strains of the collections among which most the strains (67%) included genes of *egc*cluster. Other investigation confirmed a high number of enterotoxin genes (n = 90, 56%) of the strains from Kraków ([@bib1]). Interestingly, animal strains from Gdańsk showed a low level of those genes (n = 1). This suggests that the P-like pA+ strains are less virulent than other human strains and that virulence is more comparable to animal strains. As widely known, colonization of various hosts by staphylococci requires adaptive changes, which in turn can be reflected by the acquisition of new genetic characteristics. Against the above data, it cannot be excluded that the P-like pA+ isolates described hereby are animal strains that are at a certain stage of the evolutionary process aimed at transforming them into human strains.

The human and animal strains were also compared based on the *spa* typing, and both collections had different *spa* types and *spa*-CCs. The only exception was *spa*-CC 084, containing ten human strains and an animal strain but all ten strains originated from Gdańsk. Among both human and animal strains, *spa*-CC strongly correlated with the place of strain isolation. Only one *spa*-CC 045 was identified in Świdnik (Poland) and Kosice (Slovakia), but according to Ridom SpaServer ([www.ridom.de](http://www.ridom.de)), it is one of the most common *spa*-CCs, with a global frequency of 6.03%. Our study showed that similarities between strains were more due to their geographic origin than due to the host species from which they originated. According to Ridom SpaServer ([www.ridom.de](http://www.ridom.de)) the most frequent *spa*-types in the world are t032, t003, t002, and t008. [@bib3] have analyzed the most prevalent *spa*-types occurred human strains in particular continents and countries. Authors presented that the most prevalent *spa*-types in Europe are t008, t002, and t003, while in Poland the most frequent are *spa*-types are t003, t037, t053, t127, and t021. In contrast, in our study, the majority of human strains belonged to t084, and t9490 of *spa*-CC084.

The animal strains mostly belonged to t14395, and t010, and bovine strains were grouped. According to Ridom SpaServer ([www.ridom.de](http://www.ridom.de)) the *spa* type t010 belongs to ST5, whereas in Europe the most frequent are ST97, ST126, ST133, ST151, ST497, and ST771 (Holmes and Zadoks [@bib9]).

Conclusions {#sec6}
===========

The human and animal *S. aureus* collections were characterized by the phenotypic and molecular methods. The results obtained showed that phenotypically demonstrated resistance profiles and virulence factors were comparable to microarray's profiling.

Analysis of human and animal strains did not demonstrate any specific marker clearly differentiating them in the microarray results. However, human P-like pA+ strains were characterized by lack of *hlb, sak*, and enterotoxin genes in comparison to other human strains. Moreover, the bovine mastitis strains from Poland showed sensitivity to almost all antibiotics used in the project in opposite to the Slovakian ones that demonstrated a broad range of antibiotic resistance.

Our study showed that similarities between strains were more due to their geographic origin than due to the host species from which they were isolated.
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